Literature DB >> 9637490

Intracellular formation and cell surface expression of a complex of an intact lysosomal protein and MHC class II molecules.

B Arunachalam1, M Pan, P Cresswell.   

Abstract

The generation of invariant chain-free MHC class II molecules and their association with endocytically generated peptides are thought to occur in specialized lysosome-like compartments called MIICs (MHC class II compartments). A number of in vitro studies have shown that large denatured proteins can bind to class II molecules, and that class II association can protect the bound segment of protein from proteolytic degradation. In this work, we present what we believe is the first example of an intact endogenous protein (IP30) binding in an allele-dependent fashion to class II molecules in vivo. IP30 is an IFN-gamma-inducible 35-kDa glycoprotein that localizes in MIICs. In this study, we show that intact IP30 binds to certain HLA-DR alleles via an N-terminal prosequence. The association takes place in the endocytic pathway following removal of invariant chain from class II molecules and before their cell surface expression. We also show that DR-IP30 complexes are SDS stable. The potential precursor-product relationship between DR-IP30 complexes and the DR-peptide complex is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9637490

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Differing processing requirements of four recombinant antigens containing a single defined T-cell epitope for presentation by major histocompatibility complex class II.

Authors:  L Colledge; M Y Sun ; W Lin; C C Blackburn; P A Reay
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

Review 2.  Diversity in MHC class II antigen presentation.

Authors:  John H Robinson; Alexei A Delvig
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

3.  Lineage specificity of gene expression patterns.

Authors:  Yuval Kluger; David P Tuck; Joseph T Chang; Yasuhiro Nakayama; Ranjana Poddar; Naohiko Kohya; Zheng Lian; Abdelhakim Ben Nasr; H Ruth Halaban; Diane S Krause; Xueqing Zhang; Peter E Newburger; Sherman M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

4.  Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT).

Authors:  B Arunachalam; U T Phan; H J Geuze; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 5.  Thiol oxidation and reduction in MHC-restricted antigen processing and presentation.

Authors:  P Cresswell; B Arunachalam; N Bangia; T Dick; G Diedrich; E Hughes; M Maric
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

6.  GILT expression in B cells diminishes cathepsin S steady-state protein expression and activity.

Authors:  Hannah Phipps-Yonas; Vikki Semik; Karen Taraszka Hastings
Journal:  Eur J Immunol       Date:  2012-11-26       Impact factor: 5.532

7.  Cross-reactive cytotoxic T lymphocytes against human immunodeficiency virus type 1 protease and gamma interferon-inducible protein 30.

Authors:  R D Mason; M I Bowmer; C M Howley; M D Grant
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

8.  Bordetella pertussis infection of primary human monocytes alters HLA-DR expression.

Authors:  Jennifer A Shumilla; Vashti Lacaille; Tara M C Hornell; Jennifer Huang; Supraja Narasimhan; David A Relman; Elizabeth D Mellins
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

9.  Role of the C-terminal propeptide in the activity and maturation of gamma -interferon-inducible lysosomal thiol reductase (GILT).

Authors:  Uyen T Phan; Rebecca L Lackman; Peter Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-27       Impact factor: 11.205

10.  Dynamics of major histocompatibility complex class I association with the human peptide-loading complex.

Authors:  Michaela S Panter; Ankur Jain; Ralf M Leonhardt; Taekjip Ha; Peter Cresswell
Journal:  J Biol Chem       Date:  2012-07-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.